Key result
Transcatheter mitral valve therapies offer an alternative for high-risk patients with severe mitral regurgitation, requiring advanced imaging, specific training, and a multidisciplinary approach.
This review outlines the emerging clinical and technical challenges associated with transcatheter mitral valve therapies for high-risk patients with severe mitral regurgitation.
Requires specialized centers with advanced imaging for high-risk mitral regurgitation; leaves open optimal patient selection and durability data.
Transcatheter mitral valve therapies have emerged as an alternative option in high surgical risk or inoperable patients with severe and symptomatic mitral regurgitation (MR). As multiple technologies and different approaches will become available in the field of mitral valve interventions, different challenges are emerging, both patient- (clinical challenges) and procedure-related (technical challenges). This review will briefly explore the current open challenges in the evolving fields of interventional mitral valve treatment.
No takes yet. Share an insight, caveat, or question.
Taramasso et al. (2015) conducted a review in Mitral regurgitation. Transcatheter mitral valve therapies was evaluated. Transcatheter mitral valve therapies offer an alternative for high-risk patients with severe mitral regurgitation, requiring advanced imaging, specific training, and a multidisciplinary approach.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: